| 000 | 01720cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030503.0 | ||
| 008 | 111015s2011 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.12.02.M.Sc.2011.Do.B | ||
| 100 | 0 | _aDoaa Samir Salah Eldin | |
| 245 | 1 | 0 |
_aBiochemical studies of human amylase as diagnostic enzyme and its catalytic function in normal and diabetic conditions / _cDoaa Samir Salah Eldin ; Supervised Mohamed O. I. Refaie , Mohamed Ali Eldosoky |
| 246 | 1 | 5 | _aدراسات بيوكيميائية عن الاميليز البشرى كانزيم تشخيصى ووظيفية المحفزة فى الحالات الطبيعية ومرضى السكر |
| 260 |
_aCairo : _bDoaa Samir Salah Eldin , _c2011 |
||
| 300 |
_a141 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry | ||
| 520 | _aNon - insulin - dependent diabetes mellitus (NIDDM) is caused by the secretory decrease in insulin or the lowering of insulin resistance due to excess glucose absorption . At present the direct clinical therapy in (NIDDM) is to optimize or control the postprandial blood glucose (PBG) level . Polysaccharides degrading enzymes | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAntidiabetic | |
| 653 | 4 | _aEnzymes modifiers | |
| 653 | 4 | _aHuman salivary alpha amylase | |
| 700 | 0 |
_aMohamed Ali Eldosoky , _eSupervisor |
|
| 700 | 0 |
_aMohamed Osman Ibrahem Refaie , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c35760 _d35760 |
||